In conclusion, while ample evidence exists supporting TMEM16A's involvement in the initiation and progression of prostate cancer, the inconsistencies surrounding its specific mechanisms and prognostic implications underscore the need for further research. The gene discussed is ANO1; the disease is prostate carcinoma.